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Abstract
Background: The diagnosis of fetal alcohol syndrome (FAS) rests on identification of 
characteristic facial, growth, and central nervous system (CNS) features. Public health surveillance 
of FAS depends on documentation of these characteristics. We evaluated if reporting of FAS 
characteristics is associated with the type of provider examining the child.
Methods: We analyzed cases aged 7–9 years from the Fetal Alcohol Syndrome Surveillance 
Network II (FASSNetII). We included cases whose surveillance records included the type of 
provider (qualifying provider: developmental pediatrician, geneticist, neonatologist; other 
physician; or other provider) who evaluated the child as well as the FAS diagnostic characteristics 
(facial dysmorphology, CNS impairment, and/or growth deficiency) reported by the provider.
Results: A total of 345 cases were eligible for this analysis. Of these, 188 (54.5%) had adequate 
information on type of provider. Qualifying physicians averaged more than six reported FAS 
characteristics while other providers averaged less than five. Qualifying physicians reported on 
facial characteristics and developmental delay more frequently than other providers. Also, 
qualifying physicians reported on all three domains of characteristics (facial, CNS, and growth) in 
97% of cases while others reported all three characteristics on two thirds of cases.
Conclusions: Documentation in medical records during clinical evaluations for FAS is lower 
than optimal for cross-provider communication and surveillance purposes. Lack of documentation 
limits the quality and quantity of information in records that serve as a major source of data for 
public health surveillance systems.
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1 | INTRODUCTION
Fetal alcohol spectrum disorders (FASD) are conditions with varying degrees of 
neurocognitive impairments, growth deficiency, and abnormal facial features caused by 
maternal consumption of alcohol during pregnancy, with fetal alcohol syndrome (FAS) 
representing the most well known of the FASD conditions (Farag, 2014) with both physical 
and neurobehavioral criteria. Recent estimates of the prevalence of FAS in the United States 
range from 0.3–0.8 per 1,000 children ages 7–9 years in a record-based multisite 
surveillance program (Fox et al., 2015) to 6–9 per 1,000 children using active case 
ascertainment among schoolchildren in a single representative community (May et al., 
2014). Some of this wide variation in prevalence estimates may be attributed to clinicians 
not recognizing the key characteristics of FAS and subsequently not documenting these 
characteristics in medical records, which serve as the primary data sources for records-based 
surveillance (Fox et al., 2015). It is important also to note that most children who are 
adversely affected by prenatal exposure to alcohol do not present with the physical 
characteristics of FASD such as dysmorphic facial features, which accounted for less than 
20% of exposed children in a recent prospective study (Kuehn et al., 2012).
Many types of healthcare providers evaluate children for FAS in a wide variety of clinical 
settings. In an effort to assist these providers, specific criteria have been developed to 
describe and define the elements required for diagnosis, most recently in updated clinical 
guidelines (Hoyme et al., 2016). However, the persistence of lower prevalence estimates in 
records-based surveillance studies compared to active case ascertainment suggests that many 
children with FAS are not diagnosed or are misclassified into other diagnostic categories, 
which can produce inaccurate estimates of FAS prevalence (Astley & Clarren, 2000; 
Chasnoff, Wells, & King, 2015).
The accuracy and precision of a surveillance program depends on the quality of data it 
obtains (National Birth Defects Prevention Network, 2014). If sources of potential cases are 
missed, such as clinics in which children with possible FAS are evaluated and diagnosed, the 
ultimate result is an artificially low prevalence. In addition, if critical data in records being 
abstracted are incomplete or absent altogether, the information necessary for determination 
of case status is missing and results in a lower prevalence estimate.
In this report, we examine differences in documentation of FAS features in medical records 
among healthcare providers from a recently completed population-based surveillance 
program for FAS. The goals were to determine which healthcare providers were evaluating 
children for FAS, to compute the frequencies with which clinical features and measurements 
were reported by providers in medical records, and to evaluate documentation of clinical 
information indicative of FAS by type of provider which in turn could facilitate records-
based surveillance.
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2 | METHODS
The Fetal Alcohol Syndrome Surveillance Network II (FASSNetII) was a population-based 
surveillance system that collected standardized information from multiple record sources on 
7- to 9-year old (birth years 2001–2003) children evaluated for FAS (O’Leary et al., 2015). 
Cases were obtained from Arizona, seven counties in the Denver metro area of Colorado 
(Adams, Arapaho, Boulder, Broomfield, Denver, Douglas, and Jefferson counties), and nine 
counties in western New York (Allegany, Cattaraugus, Chautauqua, Erie, Genesee, Monroe, 
Niagara, Orleans, and Wyoming counties). A full description of the FASSNetII methodology 
and the case classification algorithm has been reported previously (O’Leary et al., 2015). 
The surveillance system included all children living in the catchment areas during 2010 with 
a date of birth between January 1, 2001, and December 31, 2003. Data were abstracted from 
medical records by trained abstractors.
Medical record abstraction for FASSNetII included data for specific clinical abnormalities in 
three domains: facial dysmorphology, central nervous system (CNS) conditions, and growth. 
There were five characteristics in the facial dysmorphology domain (abnormal facial 
features, thin or narrow upper lip, abnormal philtrum, short palpebral fissures, and palpebral 
fissures less than the 10th percentile). The characteristic “abnormal facial features” reflected 
clinicians’ statements that the child had abnormal facial features consistent with a diagnosis 
of FAS. There were four characteristics in the CNS domain (attention deficit disorder or 
attention deficit hyperactivity disorder [ADD/ADHD], microcephaly, developmental delay, 
and intellectual disability) and one in the growth domain (growth deficiency). Abstraction 
included coding of distinct clinical features within each domain representing 10 unique 
characteristics. Data were not mutually exclusive and were coded as present when specific 
qualifying language or measurement was noted in the record. Table 1 presents a detailed 
description of qualifying criteria for each characteristic. Clinical characteristics were 
considered present when there was a qualitative statement in the medical record or specific 
documentation of their appearance, absent if the provider documented absence of the 
characteristic and “not reported” when there was no mention or insufficient notation of the 
characteristic in the clinical visit note. Three characteristics (palpebral fissures less than the 
10th percentile, microcephaly, and growth delay) were considered present when numerical 
measurement was reported or calculated to be less than the 10th percentile by standards 
(O’Leary et al., 2015). Developmental delay included a third category of “insufficient 
documentation” to demonstrate that providers only reported a single domain from a 
standardized developmental test.
Case definitions of confirmed and probable FAS were classified through the FASSNetII 
computed algorithm that consolidates all individual visit data entries accumulated from 
multiple record sources for each case using clinical criteria in the three domains (O’Leary et 
al., 2015). Confirmed cases contained documentation of clinical features in all three 
domains; probable cases contained documentation of features for facial dysmorphology plus 
one other domain. The remaining cases were pending, as they contained insufficient data to 
meet the previously stated case definitions. We included pending cases in these analyses 
because one of the purposes of this manuscript was to determine the frequency with which 
practitioners accurately document FAS clinical information and excluding these cases would 
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skew the analysis toward cases with documentation of more features. We only included 
pending cases for which there was either an FAS or other in utero alcohol exposure 
diagnosis code listed in the visit. Although such cases might not have enough evidence for 
case inclusion/exclusion criteria, their records contain valuable information about 
documented features.
For the primary analysis, individual visits for each case were grouped by source type and 
provider type. Source types included general or regional hospitals without pediatrics 
specialty services regularly offered; clinics and hospitals who provided specialties for 
diagnosing FAS including neonatology, developmental pediatrics, and pediatric genetics; 
other clinics without qualifying providers; and administrative databases such as birth defects 
registries, hospital discharge data, Medicaid, and vital records. Providers were grouped 
together as qualifying physicians (i.e., clinicians with specific training in assessing 
dysmorphic facial features such as developmental pediatricians, geneticists, and 
neonatologists), all other physicians, and all other nonphysician providers. For each group, 
data across all entries for each variable were coded as “reported” if any entry recorded either 
presence or absence, otherwise it was coded as not reported, except for Developmental 
Delay which had an intermediate “insufficient reporting” category when at least one but 
fewer than two testing domain results were reported.
Documentation of an FAS diagnosis in the record was noted if the source included the term 
“FAS,” “FAS suspected,” or listing of the FASD Diagnostic Categories A or B (Astley, 
2004). A diagnosis of Other FASD included documentation of “fetal alcohol effects or 
FAE,”1 “fetal alcohol spectrum disorders or FASD,” “alcohol-related neurodeve-lopmental 
disorder or ARND,” “alcohol-related birth defects or ARBD,” “Partial FAS,” or listing of 
the FASD Diagnostic Categories C through H (Astley, 2004). Other diagnosis included 
International Classification of Disease, Ninth edition (ICD-9) code 760.71 and all remaining 
FASD Diagnostic Categories (Astley, 2004). All other cases qualified as “No diagnosis in 
record” if there was no mention of an FASD diagnosis or it was specified that FASD was 
ruled out or not present. The average age at last visit was calculated using date of birth and 
the latest visit date for the source type, average number of features was determined by 
counting the number of reported features (out of 10), and average number of visits 
represented the sum of distinct visit dates by source types.
Data analyses were performed using IBM SPSS Statistics 24.0. We conducted bivariable 
analyses to examine associations between selected characteristics and surveillance site 
(Arizona, Colorado, New York). Chi-square tests were used to evaluate differences in 
proportions (p < .05). Any observations with unknown or missing responses were excluded.
NOTE
1
 The term “fetal alcohol effects” or FAE is still observed in medical records, but the Institute of Medicine recommended more than 
twenty years ago that it be replaced by the terms alcohol-related neurodevelopmental disorder (ARND) or alcohol-related birth defects 
(ARBD) (https://www.cdc.gov/ncbddd/fasd/facts.html; accessed 6/24/2017).
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3 | RESULTS
A total of 345 children in FASSNetII were eligible for study. Characteristics of these 
children are presented by surveillance site in Table 2. Across all sites, there were 130 
confirmed, 31 probable, and 184 pending cases by the FASSNetII case classification method 
(O’Leary et al., 2015) included in the analysis. Over half (192/345, 56%) were from the 
Arizona site, and overall males accounted for almost 60% of the total. The largest racial/
ethnic group overall comprised those identified as non-Hispanic White (30%) and second 
largest those identified as American Indian or Alaska Native (23%) followed by Hispanic 
(16%) and non-Hispanic Black (12%). Maternal history of alcohol use was documented for 
66% of all children. Differences among sites were identified for algorithm case status, 
clinical review case status, race/ethnicity, and maternal history of alcohol use.
We report selected characteristics of the 345 children in FASSNetII by surveillance source 
type in Table 3. In this table, individual children could be included in more than one column 
(source type), thus no statistical tests were done. With respect to case status in the source 
types, the majority reported from clinics or hospitals with specialties (113/173, 65%) and 
other clinics (70/93, 77%) were confirmed or probable cases, while confirmed/probable 
cases from general and regional hospitals (55/149, 37%) and administrative sources (50/143, 
35%) were each less than 40%. Children with the diagnosis of FAS or other FASD 
mentioned in the record were 67% or more in clinics or hospitals with specialties (116/173, 
67%) or other clinics (72/93, 77%) and less than 50% in general or regional hospitals 
(73/149, 49%) or administrative sources (7/143, 5%). The percent of children for which a 
qualifying provider was included in the record was 60% or more in general and regional 
hospitals (91/149, 61%) and clinics or hospitals with specialties (144/173, 83%), and under 
37% in other clinics (33/93, 36%) and administrative sources (5/143, 4%). The 
documentation of maternal alcohol use was similar across three source types, ranging from 
70% to 81%, while in administrative sources it was 55%. With respect to the diagnostic 
characteristics in Table 3, the average age of last visit was almost eight years in other clinics, 
while the other sources averaged five years or less. The average number of features listed 
was almost seven in clinics or hospitals with specialties, close to five in general and regional 
hospitals and other clinics, while in the administrative sources it was close to two. Finally, 
the average number of visits at other clinics was over 13, while in the other source types the 
averages were five visits or fewer.
Of the 345 children in FASSNetII eligible for study, 188 (55%) had documentation of FAS 
diagnosis indicated in records as well as adequate information in their recorded visits for the 
type of provider; data for the remaining 157 were excluded from the analysis. Comparison 
between cases included and excluded from analysis demonstrated that those cases excluded 
had an overall paucity of reportable information with a much higher proportion of cases 
classified as pending and a much larger proportion without any documentation of maternal 
alcohol use reported thereby ensuring the analysis was not skewed toward a lack of 
documentation. As reported in Table 2, the 188 children included 41% of the 192 eligible 
from AZ, 59% of the eligible 63 from CO, and 81% of the eligible 90 from NY. In Table 4, 
we display selected diagnostic characteristics reported (or not) among children seen by three 
provider types, as well as the number of features reported. As in Table 3, individual children 
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could have been seen by more than one provider type, thus no statistical tests were done. A 
total of 121 of the 188 (64%) were seen by qualifying physicians, 43% by other physicians, 
and 24% by other providers. Qualifying physicians averaged more than six reported features, 
while other physicians and other providers each averaged less than five features. With 
respect to facial characteristics, qualifying physicians reported on them for 59% of children 
or more (ranging as high as 84%), while other physicians and providers reported for 54% or 
less. For CNS characteristics, presence or absence of developmental delay was reported by 
qualifying physicians for 89% of children, while the other providers reported on 65% or less. 
Other physicians and providers reported about ADD or attention deficit hyperactivity 
disorder (ADHD) in 40% or more of children, while qualifying physicians provided 
information for 18%. Similarly, other physicians reported on intellectual disability in 16%
−20% of children, while qualifying physicians did so for 10%. Reporting presence or 
absence of microcephaly was similar across providers, ranging from 58% to 67%. All three 
provider groups reported growth information for 100% of children. And finally, qualifying 
physicians reported on all three of the domains in 97% of children, while other physicians 
and other providers reported all three in 65% and 62% of children, respectively.
Qualifying physicians will typically see children who are referred by other providers and 
could possibly be reporting more characteristics based on previous information reported by 
other physicians and providers. While we cannot completely rule out that qualifying 
physicians may have had information from previous visits influencing their documentation, 
we were able to compare whether or not those cases who saw providers in multiple 
categories differed with respect to the characteristics reported. Only 29% of cases (54/188) 
had data in more than one category of provider. Of those, 28 saw qualifying physicians and 
other physicians, 6 saw qualifying physicians and other providers, and 4 cases saw all three 
provider categories. We used a pairwise t test to compare groups and found no mean 
differences for number of features reported (data not shown). In the 28 cases with qualifying 
and other physicians, the mean number of features reported was identical at 6.14. The six 
cases with qualifying physicians (M = 7.7) and other providers reporting (M = 6.7) differed 
by one. Last, the four cases with all three provider groups demonstrated no differences in the 
three pairwise comparisons (M = 7.50 for qualifying physicians; M = 7.00 for other 
physician; and M = 5.50 for other provider).
4 | DISCUSSION
Despite the availability of diagnostic guidelines, diagnosis of FAS and documentation of this 
diagnosis in the medical record continues to be a challenge. The data we report suggest that 
much of the critical information for making the diagnosis of FAS is not being documented 
by the providers who are evaluating children for possible FAS and making the diagnosis. To 
facilitate a diagnosis of FAS, it is important for all healthcare providers to have knowledge 
of the cardinal features of the disorder, and if they do not believe themselves qualified to 
make the diagnosis of FAS, providers can collect the data needed for a comprehensive 
evaluation by a provider familiar with FAS. A previous survey of practicing primary care 
pediatricians found that they were almost universally aware of the clinical presentation of 
FAS, but that only about half of them were prepared to make the diagnosis and about a third 
were prepared to manage and coordinate treatment (Gahagan et al., 2006). Similar results 
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were found in a survey of Spanish and Italian neonatologists and pediatricians (Vagnarelli et 
al., 2011).
The basic framework of comprehensive diagnostic guidelines for FAS has been available for 
almost 20 years. Following the initial publication of FAS diagnostic categories and features 
by the Institute of Medicine (IOM) (Stratton, Howe, & Battaglia, 1996), Astley and Clarren 
developed the 4-digit scoring system to use more objective criteria than were available at 
that time, and this system subsequently underwent two revisions (Astley, 2004; Astley & 
Clarren, 1997, 2000). In 2005, Hoyme et al. proposed diagnostic guidelines based on the 
IOM criteria and designed for use in clinical pediatric practice (Hoyme et al., 2005). This 
same year saw the publication of guidelines for Canadian physicians (Chudley et al., 2005). 
These revisions were timely, as reports from some parts of the world suggested that most 
health professionals had a limited understanding of the key features of the disorder (Payne et 
al., 2005). There are limited data to indicate that diagnostic guidelines have had an impact 
on clinical practice. For example, a survey of clinics in Canada found that 74% were using 
the new diagnostic recommendations in the 2005 Canadian guidelines (Clarren, Lutke, & 
Sherbuck, 2011). However, this same evaluation reported that less than half of the clinics 
had a full staff of health professionals on site to make the diagnosis.
Some providers receive specialized training in the recognition and diagnosis of children with 
the physical features of FAS, such as geneticists/dysmorphologists and developmental 
pediatricians. This training includes the recognition of major and minor structural 
abnormalities and the application of anthropometric measurement techniques for assessment 
of growth and craniofacial features. Thus, these clinicians are often the providers to whom 
children suspected to have had prenatal alcohol exposure are referred. Previous 
investigations suggest, however, that pediatricians with training in recognition of FAS 
features can make the diagnosis with similar accuracy to expert FAS diagnosticians (Jones et 
al., 2006). Even with training in and knowledge of FAS diagnostic criteria, many providers 
who might suspect a diagnosis are reluctant to initiate a subspecialty referral over concerns 
regarding stigmatization and loss of patient physician rapport (Elliott, Payne, Haan, & 
Bower, 2006).
Some physical features diagnostic for FAS that can be assessed quantitatively include height, 
weight, head circumference, philtrum length, and palpebral fissure length. They may also be 
reported qualitatively, using descriptors such as “short palpebral fissures,” “abnormal 
philtrum,” or “abnormal facial features.” In our data, the qualifying physicians reported 
about philtrum appearance and palpebral fissure length in 59%−84% of children evaluated, 
while other providers reported in 18%−54% of children depending on the specific 
characteristic. We found that records of visits to some providers frequently failed to note 
even a qualitative assessment of philtrum appearance or palpebral fissures, with 54% of 
children containing reports about the philtrum, and palpebral fissure length described as 
short ranging from 18% to 38%. This is consistent with one post-training survey that found 
that even after training on assessing patients for FAS, many providers of care to high-risk 
patients reported that they were using growth charts to evaluate height/length and weight for 
age but did not use lip philtrum guides or palpebral fissure length measurements (Evans, 
Tenkku, Kennedy, Zoorob, & Rudeen, 2014).
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Deficiencies in growth and head circumference can be evaluated using simple, available 
tools such as a measuring tape and scale. The measurement of height, weight, and head 
circumference is standard practice for pediatric visits (Sniderman, 2010); the American 
Academy of Pediatrics guidelines recommend measurement of height/length and weight at 
every visit and of head circumference at each well child visit from birth through 24 months 
(American Academy of Pediatrics, 2010).
In our data, information concerning the child’s physical growth was reported in 100% of 
children. The presence or absence of microcephaly was consistently reported for two thirds 
of children.
The behavioral symptoms of FAS, such as ADD/ADHD and developmental delay, are 
evaluated through clinical assessment of the child’s behaviors in conjunction with input 
from parents, teachers, and other caregivers. In our data, information about ADD/ADHD 
was not reported by most providers (58%−82%), which likely reflects the dependence of the 
FASSNetII surveillance programs on medical records as a major source of data. Information 
on developmental delay was more consistently reported across provider types. We found that 
80% or more of children did not have reported information about intellectual disability, 
which again could reflect lesser access in FASSNetII to records other than those of 
healthcare providers.
4.1 | Strengths/limitations
This study has a number of strengths. The data have been generated by a multisite, 
population-based surveillance system in which the same methodology was applied across 
sites as described previously (O’Leary et al., 2015). A key component of FASSNetII was the 
implementation of a Clinical Review Committee to evaluate the case status of each potential 
case as confirmed or probable by reviewing the abstracted data on each of the cases 
presented to the committee, regardless of whether an FAS diagnosis was stated in the 
records. Finally, the 345 children we studied provide a robust sample size for examining 
questions on the diagnosis of FAS in the community.
There are a few limitations of these data. There were some differences among sites for 
certain characteristics such as case status, race/ethnicity, and maternal history of alcohol use 
that could have affected our results. Information on maternal alcohol consumption during 
pregnancy was not always available in the medical records and was not required to meet the 
case definition for FAS. The differences among sites for both the algorithm and clinical 
review case status categories likely reflect some variation from site to site in the sources 
used for case finding and abstraction as well as the sequencing of case finding among the 
sources accessed by a given surveillance site.
In addition, this study does not provide any perspective on those children with FAS who 
were not evaluated at sources to which we had access. Although a variety of clinical sources 
were included, and the record review and data collection were intended to be a 
comprehensive ascertainment of all possible cases in these communities, it is limited to 
those children who had access to clinical services at available sources. The percentage of 
records with no recorded data could have been biased upward if FAS diagnosis was not the 
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primary purpose for these visits, but we had no way to identify which visits were referrals 
for diagnosis of FAS and which were for another purpose. Another limitation of these data is 
that some providers could have failed to report data for a given diagnostic characteristic 
because the information had already been included in a child’s record by another provider. 
We have no way to determine the frequency with which this could have occurred. Finally, 
our focus on the diagnosis of FAS might have affected the surveillance data. For example, 
some children referred to certain providers for pressing behavioral or cognitive concerns 
might not have been referred in turn to a qualifying provider despite suspicions about 
possible effects of alcohol. We acknowledge that FAS is only part of the full spectrum of 
FASD, which also includes ARND, in which individuals can have intellectual disability and 
behavioral and learning issues, and ARBD involving medical problems we did not consider.
4.2 | Conclusions/implications
The conclusions that emerge from this study are as follows:
1. In this FAS surveillance data set, the documentation in medical records during 
clinical evaluations for FAS is lower than optimal for cross-provider 
communication and surveillance purposes.
2. For dysmorphic facial features characteristics that are required for making the 
diagnosis of FAS, qualifying providers are more apt to report the required 
information.
3. Given that qualifying providers are not the only providers who evaluate children 
with potential FAS or make the diagnosis of FAS, there seems to be a need to 
improve documentation practices to facilitate communication across providers 
(both diagnostic and treatment) as well as allow for public health surveillance of 
FAS.
There are several implications of these findings for surveillance. Without the data necessary 
to determine if children have FAS or not, FAS surveillance projects will not identify all 
potential cases of this condition. Therefore, it appears that low prevalence estimates in many 
public health surveillance programs for FAS could, at least in part, be the result of the lack 
of the essential data in the medical records on which these programs rely. Case finding using 
the case classification algorithm by surveillance systems and in databases of electronic 
health records has the potential to ensure that a higher proportion of FAS cases are provided 
with services they need. However, our results clearly demonstrate that the information 
necessary to identify cases by these methods is often not indicated in records by the 
providers who are evaluating children for FAS.
From a clinical perspective, these results suggest a continuing need to train physicians and 
other healthcare providers and increase awareness of the importance of recording 
information whenever a child is suspected of having FAS. Despite efforts to educate 
physicians and other providers about FAS and the importance of early intervention, absence 
of critical information in the medical records of at-risk children limits their identification 
solely from the medical record. Public health programs for diagnosis and treatment of 
children with FAS that combine information from multiple sources such as school records, 
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early intervention programs and medical sources may prove especially useful and are worthy 
of further investigation.
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Table 1
Definitions of the 10 FAS characteristics across the three domains
Characteristic Qualifies Does not qualify
Abnormal facial features 
consistent with FAS
• Appears to have, somewhat, mild, slight, some, minor, relatively, subtle 
(features). (Statement should also mention FAS.)
• Many characteristics of FAS (only if this is marked in the HEENT or 
face part of the examination)
• Minor stigmata of FAS, some facial features consistent with FAS or 
some facial features associated with the fetal alcohol spectrum of effects
• Baby with features of FAS or mild FAS
• Facial manifestations of individuals with FAS
• Has typical FAS morphology
• Abnormal facies
• FAS facial features 
questioned
• Minor dysmorphic features 
with no recognizable syndrome
• Slight stigmata of FAE or 
features suggestive of FAE
• Subtle facial features
• Unusual facial appearance
• Face is mildly dysmorphic
Thin or narrow upper lip • Small upper lip
• Attenuated upper lip
• Indistinct Vermillion border
• Poorly defined cupid’s bow
• Vermillion is somewhat diminished
• Mildly undermodeled border of upper lip
• Vermillion/lip rating 4 or 5 (IV or V)
• Astley scale = 4 or 5 (with mention of Vermillion or lip)
• Likert scale = 4 or 5 (with mention of Vermillion or lip)
• Lip/vermillion guide value = 4 or 5
• Short upper lip
• Astley scale < 4 (lip)
• Likert scale < 4 (lip)
• Vermillion/lip guide value <4
Abnormal
Philtrum
• Poorly formed philtrum
• Minimal philtrum
• Smooth philtral columns
• Philtral Rating 4 or 5 (IV or V)
• Smooth upper lip (equivalent to “smooth philtrum”)
• Astley scale = 4 or 5 (with mention of philtrum)
• Likert scale = 4 or 5 (with mention of philtrum)
• Philtrum Guide Value = 4 or 5
• Short philtrum
• Likert scale <IV (philtrum)
• Astley scale <4 (philtrum)
• Likert scale <4 (philtrum)
• Philtrum Guide Value <4
Short palpebral fissures • Appears to have somewhat narrow palpebral fissures
• Eyes appear small
• Narrow palpebral fissures or “PF”
• Mild widening of inner canthus
• Broad inner canthus
• Telecanthus
Palpebral fissures <≤ 10th 
percentile
• Measurements ≤10th percentile at birth or any age
Characteristic Qualifies Does not qualify
ADD or ADHD • “ADD” or attention deficit disorder
• “ADHD” or attention deficit hyperactivity disorder
Microcephaly • Decreased cranial size at birth
• Microcephaly
• Cerebellar Hypoplasia
• Partial or complete agenesis of the corpus callosum
• Head circumference < 10th percentile at birth or any age
Developmental delay • Minimum of two out of ten domains reported for either presence or 
absence • ≥2 domains that are ≥1 standard deviation below the mean
• Clinical diagnosis of a developmental disorder
• Documentation of Global Developmental Delay
Intellectual disability • Intellectual delay
• Low cognitive function
• Mental retardation (older records)
• Standardized IQ > 2 standard deviations below the mean
Growth delay • Weight or height ≤ 10th percentile for age
• Weight or height corrected for gestational age < 10th percentile
• Weight for height ≤ 10th percentile
Note. FAS, fetal alcohol syndrome; FAE, fetal alcohol effects; IQ, intelligence quotient; HEENT, head, ears, eyes, nose, and throat.
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Table 2
Selected characteristics and univariate results of 345 children in FASSNetII
All sites
(n = 345)
Arizona
(n = 195)
Colorado
(n = 63)
New York
(n = 90)
N % N % N % N %
Algorithm case statusa
    Confirmed 130 37.7 52b 27.1 21 33.3 57b 63.3
    Probable 31 9.0 15 7.8 8 12.7 8 8.9
    Pending 184 53.3 125b 65.1 34 54.0 25b 27.8
Clinical review case statusa, c
    FAS with alcohol exposure 83 24.1 33 17.2 12 19.0 38 42.2
    FAS without alcohol 7 2.0 2 1.0 1 1.6 4 4.4
    Probable FAS with alcohol 30 8.7 12 6.3 9 41.3 9 10.0
    Probable FAS without alcohol 14 4.1 6 3.1 3 4.8 5 5.6
    Not an FAS case 35 10.1 17 8.9 5 7.9 13 14.4
    Not reviewed 176 51.0 122 63.5 33 52.4 21 23.3
Gender
    Male 205 59.4 115 59.9 39 61.9 51 56.7
    Female 140 40.6 77 40.1 24 38.1 39 43.3
Race/ethnicitya
    White 103 29.9 32b 16.7 27 42.9 44 48.9
    Hispanic 55 15.9 31 16.1 16 25.4 8 8.9
    Black or African American 41 11.9 8b 4.2 6 9.5 27b 30.0
    American Indian or Alaska Native 79 22.9 73b 38.0 3b 4.8 3b 3.3
    Other 14 4.1 6 3.1 5 7.9 3 3.3
    Unknown 53 15.4 42b 21.9 6 9.5 5b 5.6
Maternal history of alcohol usea, d
    Yes 229 66.4 115 59.9 48 76.2 66 73.3
    No 116 33.6 77 40.1 15 23.8 24 26.7
Inclusion
    Table 3 sourcese 345 100.0 192 100.0 63 100.0 90 100.0
    Table 4 providersf 188 54.5 78 40.6 38 58.7 73 81.1
Note. FAS, fetal alcohol syndrome; FASSNetlI, Fetal Alcohol Syndrome Surveillance Network II.
a
 Chi-square significant at p < .05.
b
 Cell standardized residuals > |2|.
c
 Two FAS rows, two probable FAS rows, and two rows for not an FAS case, and not reviewed were collapsed to avoid issues with small expected 
frequencies.
d
 documentation in any abstracted record of maternal alcohol use during the index pregnancy.
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e
 Table 3 sources refers to surveillance source types shown in Table 3 including general or regional hospital, clinic or hospital with specialties, 
other clinic, and administrative source.
f
 Table 4 providers: provider types shown in Table 4 including qualifying physician, other physician, and other provider, as described in detail in 
Table 4.
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Table 3
Selected positive characteristics by source type for 345 children in FASSNetII
FASSNetII children, N = 
345
General or regional 
hospital
Clinic or hospital with 
specialties Other clinica
Administrative
source
N Column % N Column % N Column % N Column %
Total Children 149 173 93 143
Algorithm case status
    Confirmed 47 31.5 89 51.4 65 69.9 44 31.0
    Probable 8 5.4 24 13.9 7 7.5 6 4.2
    Pending 94 63.1 60 34.7 21 22.6 93 65.0
Diagnosis mentioned in record
    FAS 58 38.9 93 53.8 65 69.9 6 4.2
    Other FASD 15 10.1 23 13.3 5 5.4 1 0.7
    Other diagnosis 28 18.8 10 5.8 4 4.3 135 94.4
    None 48 32.2 47 27.2 19 20.4 1 0.7
Maternal alcohol use documentedb
    Yes 106 71.1 122 70.5 75 80.6 79 55.2
    No 43 28.9 51 29.5 18 19.4 64 44.8
Providers
    Qualifying provider includedc 91 61.1 144 83.2 33 35.5 5 3.5
    No qualifying providers 41 27.5 29 16.8 57 61.3 121 84.6
    No provider type listed 17 11.4 0 0.0 3 3.2 17 12.0
Mean SD Mean SD Mean SD Mean SD
Diagnostic characteristics
    Average age at last visit in years 3.56 3.21 4.65 3.17 7.83 2.07 2.63 2.91
    Average number of features 
listed
5.42 2.12 6.94 1.92 4.91 1.98 2.27 .98
    Average number of visits at 
source
5.06 5.18 5.41 5.12 13.16 8.10 1.59 .97
Note. FAS, fetal alcohol syndrome; FASD, fetal alcohol spectrum disorders; FASSNetlI, Fetal Alcohol Syndrome Surveillance Network II.
a
 Early intervention program, primary care, psychiatry/psychology, unknown source type.
b
 documentation in any abstracted record of maternal alcohol use during the index pregnancy.
c
 Developmental Pediatrician, Geneticist, or Neonatologist.
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Table 4
Selected diagnostic characteristics and univariate results of FASSNetII recorded visits with documentation of 
FAS diagnosis by pro-vider type among 188 childrena
Qualifying physicianb Other physicianc Other providerd
N Column % N Column % N Column %
Total number of children with visits by physician type 121 64.4 80 42.6 45 23.9
Facial dysmorphology
    Abnormal facial features
        Reported 72 59.5 30 37.5 16 35.6
        Not reported 49 40.5 50 62.5 29 64.4
    Thin or narrow upper lip
        Reported 92 76.0 39 48.8 22 48.9
        Not reported 29 24.0 41 51.3 23 51.1
    Abnormal philtrum
        Reported 102 84.3 43 53.8 24 53.3
        Not reported 19 15.7 37 46.3 21 46.7
    Short palpebral fissures
        Reported 71 58.7 30 37.5 8 17.8
        Not reported 50 41.3 50 62.5 37 82.2
    Palpebral fissures < 10th percentile
        Reported 93 76.9 27 33.8 15 33.3
        Not reported 28 23.1 53 66.3 30 66.7
Central nervous system
    ADD or ADHDe
        Reported 22 18.2 34 42.5 18 40.0
        Not reported 99 81.8 46 57.5 27 60.0
    Microcephaly
        Reported 81 66.9 52 65.0 26 57.8
        Not reported 40 33.1 28 35.0 19 42.2
    Developmental delayf
        Reported 108 89.3 52 65.0 6 13.3
        Not reported 13 10.7 28 35.0 39 86.7
        Insufficient documentation 6 2 1
    Intellectual disability
        Reported 12 9.9 13 16.3 9 20.0
        Not reported 109 90.1 67 83.8 36 80.0
Growth
    Reported 121 100.0 80 100.0 45 100.0
    Not reported 0 0.0 0 0.0 0 0.0
All domains listed
    No 4 3.4 28 35.0 16 38.1
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Qualifying physicianb Other physicianc Other providerd
N Column % N Column % N Column %
    Yes 115 96.6 52 65.0 26 61.9
Mean SD Mean SD Mean SD
Diagnostic characteristics
    Average number of features 6.35 1.50 4.98 2.11 4.18 2.15
Note. FAS, fetal alcohol syndrome; FASSNetlI, Fetal Alcohol Syndrome Surveillance Network II; ADD, attention deficit disorder; ADHD, 
attention deficit hyperactivity disorder; SD, standard deviation.
a
 The remaining cases in the data set had undocumented practitioner data or practitioners were of unknown specialty.
b
 Developmental Pediatrician, Geneticist, or Neonatologist.
c
 Psychiatrist, neurologist, or other physician type.
d
 Nonphysician provider.
e
 ADD or ADHD was only documented if positive in the medical record, therefore not reported likely includes “no” responses.
f
 developmental delay includes either a diagnosis of global delay or documentation of 2 of 9 possible domains. Insufficient documentation includes 
cases documenting only1domain. These data were considered missing.
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